Lumos Pharma(LUMO) - 2023 Q1 - Earnings Call Transcript

Lumos Pharma, Inc. (NASDAQ:LUMO) Q1 2023 Results Conference Call May 3, 2023 4:30 PM ET Company Participants Lisa Miller - Senior Director, IR Rick Hawkins - CEO & Chairman Lori Lawley - CFO & Principal Accounting Officer David Karpf - Chief Medical Officer John McKew - Chief Scientific Officer & President Conference Call Participants Catherine Novack - Jones Trading Charles Duncan - Cantor Fitzgerald Leland Gershell - Oppenheimer Ed White - H.C. Wainwright & Co Yasmeen Rahimi - Piper Sandler Good afternoon ...